DAVID M. KNOTT

Corporate Board Profile

Tech Score: 0/100

LIGAND PHARMACEUTICALS INC

Filing Date	Source Excerpt
2014-04-21	David M. Knott(A)(C) Director 2007 69 ... The audit committee currently consists of Messrs. Knott and Patel and Dr. Sabba (chair). ... The compensation committee consists of Messrs. Aryeh, Davis (chair) and Knott and Dr. LaMattina. ... David Knott(3) 61,000 94,478 149,647 — 305,125 ... (3) As of December 31, 2013, Mr. Knott held options to purchase 30,338 shares of our common stock and 2,925 unvested shares of restricted stock. During 2013, Mr. Knott received 2,925 restricted stock units with a grant date fair value of $94,478 and 7,335 stock options with a grant date fair value of $149,647. Mr. Knott elected to receive 1,393 shares of fully vested stock in lieu of $45,000 of his 2013 cash retainer for his services as a non-employee director.
2015-03-13	David M. Knott(A) - Director, Age 70, Member of the audit committee (A). Compensation: $272,659 in 2014.

Filing Date

Source Excerpt

2014-04-21

David M. Knott(A)(C) Director 2007 69 ... The audit committee currently consists of Messrs. Knott and Patel and Dr. Sabba (chair). ... The compensation committee consists of Messrs. Aryeh, Davis (chair) and Knott and Dr. LaMattina. ... David Knott(3) 61,000 94,478 149,647 — 305,125 ... (3) As of December 31, 2013, Mr. Knott held options to purchase 30,338 shares of our common stock and 2,925 unvested shares of restricted stock. During 2013, Mr. Knott received 2,925 restricted stock units with a grant date fair value of $94,478 and 7,335 stock options with a grant date fair value of $149,647. Mr. Knott elected to receive 1,393 shares of fully vested stock in lieu of $45,000 of his 2013 cash retainer for his services as a non-employee director.

2015-03-13

David M. Knott(A) - Director, Age 70, Member of the audit committee (A). Compensation: $272,659 in 2014.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22